Concepedia

R. V. J. CHARI

RV

Statistics

Publications

6

Citations

643

H-Index

6

Active since

1981

Affiliations

ImmunoGen (United States)(Current)

Yale University

R. V. J. CHARI is an author at ImmunoGen (United States) specializing in cancer pharmacology, cytotoxic chemotherapy, and pharmacology.

Publications per year

1981–2010

6

Publications

6

Immunoconjugates containing novel maytansinoids: promising anticancer drugs.

R. V. J. CHARI, B. Martell, Janet L. Gross et al. · PubMed · 1992 · 266 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Eradication of large colon tumor xenografts by targeted delivery of maytansinoids.

C. Liu, B. Mitra Tadayoni, Lizabeth A. Bourret et al. · Proceedings of the National Academy of Sciences · 1996 · 197 citations · Full text

Medicine, Oncology, Pharmacology +17

Enhancement of the selectivity and antitumor efficacy of a CC-1065 analogue through immunoconjugate formation.

R. V. J. CHARI, K A Jackel, Lizabeth A. Bourret et al. · PubMed · 1995 · 99 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Deuterium isotope effects on the product partitioning of fluoromethylglyoxal by glyoxalase I. Proof of a proton transfer mechanism.

R. V. J. CHARI, John W. Kozarich · Journal of Biological Chemistry · 1981 · 36 citations · Full text

Life Sciences, Biochemistry, Chemistry +11

Postmenopausal Hyperandrogenism of Ovarian Origin

R. V. J. CHARI, H.‐D. MUELLER, David C. Cumming et al. · Gynecologic and Obstetric Investigation · 2010 · 26 citations

Medicine, Endocrinology, Gynecology +17

1–5 of 6